But as medical technologies evolved and treatments became more targeted, he found his company was spending more and more time isolating and capturing components of the blood called mononuclear cells, which are critical to the immune system — and an integral component in today’s cutting-edge cell therapies.
False Positive
No Chip on Their Shoulder
[embed width="600"]https://www.youtube.com/watch?v=xpQdfwcpJP8[/embed]
The first biopharmaceutical drugs using complex organic molecules produced by genetically modified cells to deliver more efficient therapies have already started to write the next chapter of medicine. Treatments designed from lab-made versions of large proteins are now being used to treat cancers and autoimmune disorders like multiple sclerosis. Research shows they might also do well against infectious diseases.